[Norwegian drug policy--socioeconomically unprofitable, hostile to patients and to research].
Explore the source record for details and available documents.
Cost-Benefit Analysis↗
Biomedical subjects
Publications and source records attributed to T K Jacobsen.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.